In 1874, the company was commissioned to manufacture the kilogram reference standard, made from 90% platinum and 10% iridium, and held in the Bureau International des Poids et Mesures ( International Bureau of Weights and Measures), and copies of it for international distribution. Johnson Matthey similarly also produced the International Prototype Metre and its copies. [6] 20th century edit Like all catalysts, enzymes increase the rate of a reaction by lowering the activation energy. However, one advantage of biocatalysts over chemical technologies like chemocatalysts include their ability to function under mild reaction conditions – as well as their low physiological toxicity and environmental impact. In pharmaceutical manufacturing, these advantages translate to reduced operating costs and waste, as well as simplified production routes. The most desired properties of biocatalysts include their high levels of stereo-, regio- and chemo-selectivity. Compared to traditional chemocatalysts, enzyme catalysts often reach much higher levels of selectivity. This makes them an invaluable technology for the asymmetric synthesis of chiral intermediates. The importance of chirality within the pharmaceutical industry is well-documented and current research estimates that nearly 95% of drugs will be chiral by 2020. JOHNSON MATTHEY PLC overview - Find and update company information - GOV.UK". Companies House. 11 April 1891 . Retrieved 5 September 2023.

a b c Reece, Damian (25 March 2012). "Spark-plug maker Johnson Matthey is a breath of fresh air for all of us". Telegraph.co.uk . Retrieved 3 March 2019.

Removing pollutants through catalysis

La-Niece, Susan (1993). Metal Plating and Patination: Cultural, technical and historical developments. Butterworth-Heinemann. p. 222. ISBN 978-0750616119. Change the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section. What happens at the end of my trial? In recent years, the drug discovery process has shifted towards increasingly complex active pharmaceutical ingredients (APIs). These compounds often require multiple synthetic steps, greatly lowering the atom economy of their associated processes. Additionally, these processes are carried out in organic solvents, with large quantities of chemical reagents in the form of oxidants, reductants, and acids and bases. Using these chemicals means high waste levels and costly waste treatment processes. These factors have led to an increased desire for alternative technologies that can deliver effective, safe and cost-effective drug development and manufacture. Consequently, nature’s approach to chemical innovation sparked the pharmaceutical industry’s interest. Institute of Chartered Secretaries and Administrators (2012). Awards Report 2012 – Delivering transparency, changing behaviour (PDF) (Report). Institute of Chartered Secretaries and Administrators. p. 5 . Retrieved 15 November 2014.

It is important to realise that biocatalysis and chemocatalysis are complementary technologies. When efficiently applied to the pharmaceutical process, these technologies can combine to greatly improve the drug manufacturing process, both economically and environmentally. When designing new processes for innovative APIs, it is important that pharmaceutical companies collaborate with experts in both of these fields. JM’s ability to leverage its wide-ranging catalysis expertise and manufacturing capabilities allows for faster and deeper integration of these technologies into manufacturing processes. Johnson Matthey to buy Argillon for €214 million". Reuters. 18 April 2011 . Retrieved 30 January 2012. While it will be some time before significant volumes of automotive batteries are in operation or at the end of their useful life, JM is looking at all areas of battery activities across their life cycle.Johnson Matthey sells its gold and silver refining business". The Daily Telegraph. 15 December 2014 . Retrieved 3 March 2019.

If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for 65 € per month. Metallic elements are common in eLNO battery cathode technologies, autocatalysts, industrial catalysts, healthcare devices and pharmaceuticals. However, combining and applying these elements to the specific applications requires an in-depth understanding of metallurgy and specific reaction, manufacturing and development processes. In addition, sustainability must be a high priority; it is essential that raw elemental metals are acquired sustainably over the long term. Innovation in the chemical industry relies on combining the right elements with the right expertise to make a reaction or product successful. Utah gold and silver refinery sentenced for Clean Water Act violation". Yosemite.epa.gov . Retrieved 18 April 2011. In 2014, the company was shortlisted for Business in the Community's Responsible Business of the Year Award for its Sustainability 2017 programme. [17] Limonene is a relatable example of the dramatic effect chirality can have on a molecule. A naturally occurring hydrocarbon found in citrus, limonene’s structure has a chiral centre. Like many other flavour and fragrance molecules it is found in nature as two enantiomers, ( R)- and ( S)-limonene. Although these molecules hold identical physical properties, the difference in chirality can lead to different biological properties. In this case, ( R)-Limonene is the isomer that contributes to the smell of oranges, whereas ( S)-limonene has an aroma similar to turpentine or lemon. For drug manufacturers, the ability to consistently and reliably produce one enantiomer is crucial. This is because often only one of a drug’s enantiomers is responsible for the desired physiological and therapeutic effects – while the other enantiomer is less active, inactive or even harmful. Enzymes provide manufacturers with an effective technology to produce optically pure drugs. Tomorrow’s biocatalysts todayAutomotive Components Remain A Key Driver of Macedonian Exports Despite the Pandemic". China CEE Institute . Retrieved 11 March 2022.

Understanding the chemical and physical properties of specific elements is important for industry, but leveraging and combining those properties successfully for industrial applications requires skill and expertise. Johnson Matthey (JM) has more than 200 years of experience in applying scientific research to develop solutions to the major challenges that society will face today and in the future. Over the years, JM has applied its experience and expertise in metallurgical research to develop materials to give us cleaner air, innovative catalysts for vital chemical industry processes and novel materials for cross-coupling and other industrially relevant reactions. JM has also developed technologies to recover and recycle PGMs, thereby ensuring these finite and valuable metals are available for reuse. Elements that power our vehicles Johnson Matthey is organised into four main businesses: Clean Air, Catalyst Technologies, Hydrogen Technologies, and Platinum Group Metals Services. [19] Factories in Europe edit Current lithium-ion battery materials typically include larger quantities of cobalt. This element is in limited supply and thus rising demand has caused the price to quadruple in recent years. However, cobalt is currently a critical component for ensuring lithium-ion battery stability and lifetime. Johnson Matthey Opens Major New European Emission Control Catalyst Plant in Macedonia". Business Wire. 30 January 2012 . Retrieved 30 January 2012.

About JM Elements

Battery technologies are central to electric vehicles, which have an increasing role in transportation strategies. The UK government has pledged that half of all new car sales will be hybrid or electric by 2030.